(Press-News.org) WHAT:
The rise of several significant variants of SARS-CoV-2, the virus that causes COVID-19, has attracted the attention of health and science experts worldwide. In an editorial published in JAMA: The Journal of the American Medical Association, experts from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, outline how these variants have arisen, concerns about whether vaccines currently authorized for use will continue to protect against new variants, and the need for a global approach to fighting SARS-CoV-2 as it spreads and acquires additional mutations.
The article was written by NIAID Director Anthony S. Fauci, M.D.; John R. Mascola, M.D., director of NIAID's Vaccine Research Center (VRC); and Barney S. Graham, M.D., Ph.D., deputy director of NIAID's VRC.
The authors note that the overlapping discovery of several SARS-CoV-2 variants has led to confusing terms used to name them. The appearance of SARS-CoV-2 variants is so recent that the World Health Organization and other groups are still developing appropriate nomenclature for the different variants.
Numerous SARS-CoV-2 variants have emerged over the last several months. The authors note that the variants known as B.1.1.7 (first identified in the United Kingdom) and B.1.351 (first identified in South Africa) concern scientists because of emerging data suggesting their increased transmissibility.
Variants can carry several different mutations, but changes in the spike protein of the virus, used to enter cells and infect them, are especially concerning. Changes to this protein may cause a vaccine to be less effective against a particular variant. The authors note that the B.1.351 variant may be partially or fully resistant to certain SARS-CoV-2 monoclonal antibodies currently authorized for use as therapeutics in the United States.
The recognition of all new variants, including a novel emergent strain (20C/S:452R) in California, requires systematic evaluation, according to the authors. The rise of these variants is a reminder that as long as SARS-CoV-2 continues to spread, it has the potential to evolve into new variants, the authors stress. Therefore, the fight against SARS-CoV-2 and COVID-19 will require robust surveillance, tracking, and vaccine deployment worldwide.
The authors also note the need for a pan-coronavirus vaccine. Once researchers know more about how the virus changes as it spreads, it may be possible to develop a vaccine that protects against most or all variants. While similar research programs are already in place for other diseases, such as influenza, the changing nature of SARS-CoV-2 indicates that they will be necessary for this virus.
ARTICLE:
JR Mascola et al. SARS-COV-2 Viral variants--Tackling a moving target. JAMA DOI: 10.1001/jama.2021.2088 (2021).
WHO:
NIAID Director Anthony S. Fauci, M.D., John R. Mascola, M.D., director of NIAID's Vaccine Research Center (VRC); and Barney S. Graham, MD, PhD, Deputy Director of NIAID's VRC, are available for comment.
CONTACT:
To schedule interviews, please contact
Elizabeth Deatrick,
(301) 402-1663,
NIAIDNews@niaid.nih.gov.
INFORMATION:
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health®
How much does a power system's reliability depend on the temperature? Electric power system generator resource adequacy modeling is designed to help determine capacity requirements for electric power system operators across the United States. While calculating resource adequacy requirements has been done for a century, it requires ongoing attention as the generation mix is constantly expanding and changing. A new paper contributes to these ongoing reliability considerations by using a unique data set to determine how both low and high temperatures reduce the reliability of coal, gas, diesel, hydroelectric, and nuclear power generators and thus affect the amount of generation markets should contract for.
The paper, "Resource Adequacy Implications ...
In a courtesy call to HE the President of Malta at San Anton Palace on Thursday, February 11, 2021, Dr Noel Aquilina from the Department of Chemistry, accompanied by Professor Emmanuel Sinagra, Head of the Department of Chemistry and Dean of the Faculty of Science at the University of Malta, presented the findings of a landmark study. This study shows and confirms that airborne particulate matter (PM), apart from several toxic components, is also contaminated with tobacco smoke-driven particulates.
After 30 years, Dr Noel Aquilina, alongside world renowned tobacco smoke-related researchers, ...
The Internet has revolutionized our lives - whether in terms of working, finding information or entertainment, connecting with others, or shopping. The online world has made many things easier and opened up previously unimaginable opportunities. At the same time, it presents both individuals and societies with major challenges: The underlying technologies do not necessarily serve users' best interests.
"We're interested in questions such as: How can we create online environments that respect human autonomy and promote truth? And what can people themselves do to avoid being ...
An international team of scientists has determined how harmless E. coli gut bacteria in chickens can easily pick up the genes required to evolve to cause a life-threatening infection. Their study, published in Nature Communications, warns that such infections not only affect the poultry industry but could also potentially cross over to infect humans.
E. coli is a common bacterium that lives in the intestines of most animals, including humans. It is usually harmless when it stays in the gut, however it can become very dangerous if it invades the bloodstream, causing ...
"We are surrounded by a huge number of systems - biological, technical, economic, which we can influence, which we can control. The task is to do it optimally, for example, reaching the desired point with a minimum of effort, resources, and time, - explains Prof. Yurii Averboukh. - From a mathematical point of view, the task is narrowed down to the theory of optimal control. A classic example of this theory is moon landing: fuel consumption optimization enables to increase cargo volumes transported to the moon".
A special section of optimal control theory is the theory of differential games. It studies the control ...
Sophia Antipolis, 12 February 2021: An active lifestyle is linked with a lower chance of dying immediately from a heart attack, according to a study published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1
Heart disease is the leading cause of death globally and prevention is a major public health priority. The beneficial impact of physical activity in stopping heart disease and sudden death on a population level is well documented. This study focused on the effect of an active versus sedentary lifestyle on the immediate course of a heart attack - an area with ...
A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics. With an algorithm they devised themselves, scientists at the University of Gothenburg show the capacity of technology to perform at the same level as dermatologists in assessing the severity of skin melanoma.
The study, published in the Journal of the American Academy of Dermatology, and its results are the work of a research group at the Department of Dermatology and Venereology at Sahlgrenska Academy, University of Gothenburg.
The study was conducted at Sahlgrenska University ...
Novel genetic associations could pave the way for early interventions and personalized treatment of an incurable condition.
Scientists from the University of Bergen (Norway) and Karolinska Institutet (Sweden) have discovered the genes involved in autoimmune Addison's disease, a condition where the body's immune systems destroys the adrenal cortex leading to a life-threatening hormonal deficiency of cortisol and aldosterone.
Groundbreaking study
The rarity of Addison's disease has until now made scanning of the whole genome for clues to the disease's genetic origins difficult, as this method normally requires many thousands of study participants. However, by combining the world's two largest ...
Tumor cells are able to avoid the attack of the immune system through several mechanisms. For instance, these can secrete factors that turn macrophages -cells in the immune system- into dual action agents that contribute to the tumor progress and will protect it from immune body defences: these become, thus, the tumor-associated macrophages (TAMs).
An article published in the journal Cancer Research describes a new molecular mechanism that counteracts the immunosupressive action of these macrophaes to boost tumor growth, and brings knowledge of potential interest for the design of future therapeutical options against cancer. The preclinical study is led by the tenure-track 2 lecturer Annabel Valledor, from the Faculty ...
Most tumors consist of a heterogenous mix of cells. Genetic mutations found only in some of these cells are known to aid with the spread and progression of cancer. However, oncologists often find that when tumors metastasize to distant organs, they retain this heterogenous nature--a phenomenon termed "polyclonal metastasis". The mechanism by which non-metastatic cells accompany the metastatic cells is ambiguous. Now, Masanobu Oshima and his research team have used mouse models to explain how non-metastatic cells begin their long commute.
The team has previously developed various cancerous mutants of mice and analyzed ...
